These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6553108)

  • 1. A rational approach to drug use in pregnancy.
    Zacharias J
    JOGN Nurs; 1983; 12(3):183-7. PubMed ID: 6553108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic drugs in pregnancy.
    Stanley FJ; Bower C
    Med J Aust; 1986 Dec 1-15; 145(11-12):596-9. PubMed ID: 3099136
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug use during pregnancy and breast-feeding. A classification system for drug information.
    Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
    Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Dependent Teratology in Humans: Clinical Implications for Prevention.
    Koren G; Berkovitch M; Ornoy A
    Paediatr Drugs; 2018 Aug; 20(4):331-335. PubMed ID: 29725877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratology for the obstetrician.
    Goodner DM
    Clin Obstet Gynecol; 1975 Dec; 18(4):245-63. PubMed ID: 765036
    [No Abstract]   [Full Text] [Related]  

  • 6. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age.
    Lindhout D; Omtzigt JG
    Epilepsia; 1994; 35 Suppl 4():S19-28. PubMed ID: 8174516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human teratogens update 2011: can we ensure safety during pregnancy?
    Rasmussen SA
    Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):123-8. PubMed ID: 22328359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research challenges for drug-induced birth defects.
    Mitchell AA
    Clin Pharmacol Ther; 2016 Jul; 100(1):26-8. PubMed ID: 27037730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods for studying drug risk during pregnancy].
    Autret-Leca E; Jonville-Béra AP; Cissoko H
    Arch Pediatr; 2000 May; 7 Suppl 2():404s-406s. PubMed ID: 10904789
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug use during pregnancy: are risk classifications more dangerous than the drugs?
    Bianca S
    Lancet; 2003 Jul; 362(9380):329. PubMed ID: 12892970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preclinical trials for predicting fetal risk].
    Guittin P
    Arch Pediatr; 2000 May; 7 Suppl 2():401s-403s. PubMed ID: 10904788
    [No Abstract]   [Full Text] [Related]  

  • 13. Methodologic problems encountered in investigating the possible teratogenic effects of drugs.
    Yerushalmy J
    Adv Exp Med Biol; 1972; 27():427-40. PubMed ID: 4680137
    [No Abstract]   [Full Text] [Related]  

  • 14. [When pregnant patients become ill].
    Kreuz DG
    Kinderkrankenschwester; 2011 Nov; 30(11):469. PubMed ID: 22165518
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy.
    Feldkamp M; Carey JC
    Teratology; 1993 Jun; 47(6):533-9. PubMed ID: 8367826
    [No Abstract]   [Full Text] [Related]  

  • 16. Teratogenic risk with etretinate and acitretin treatment.
    Geiger JM; Baudin M; Saurat JH
    Dermatology; 1994; 189(2):109-16. PubMed ID: 8075435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG educational bulletin. Teratology. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1997 Apr; 57(1):81-8. PubMed ID: 9175676
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs of abuse: teratogenic and mutagenic considerations.
    Evans MA; Stevens MW; Mantilla-Plata B; Harbison RD
    Addict Dis; 1975; 2(1-2):45-61. PubMed ID: 1163373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug noxae as indications for pregnancy interruption].
    Neubert D
    Internist (Berl); 1978 May; 19(5):304-9. PubMed ID: 350801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratogenic risks of high-dosage vitamin A].
    Knijn GJ; Cornel MC; de Jong-van den Berg LT; de Smet PA
    Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2060-5. PubMed ID: 1407207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.